Australia: Avance Clinical expands into North America with C3 Research acquisition

Avance Clinical, the largest premium full-service Australian CRO, has expanded into North America with the acquisition of CRO partner company C3 Research Associates. The company  has backing from private equity group Riverside Company for their global expansion programme. Avance Clinical is an established Australian and New Zealand CRO with a track-record of data acceptance by…

You must be a HMI Subscriber to view this content.

Subscribe Now »